Novavax Financials
| NVV1 Stock | EUR 8.31 0.26 3.03% |
Novavax |
Novavax Stock Summary
Novavax competes with Moderna, BioNTech, Superior Plus, SIVERS SEMICONDUCTORS, and NorAm Drilling. Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. NOVAVAX INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1541 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US6700024010 |
| Business Address | 21 Firstfield Road, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.novavax.com |
| Phone | 240 268 2000 |
| Currency | EUR - Euro |
You should never invest in Novavax without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Novavax Stock, because this is throwing your money away. Analyzing the key information contained in Novavax's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Novavax Key Financial Ratios
There are many critical financial ratios that Novavax's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Novavax reports annually and quarterly.| Return On Equity | -8.98 | |||
| Return On Asset | -0.32 | |||
| Target Price | 264.2 | |||
| Beta | 1.72 | |||
| Z Score | 1.2 |
Novavax Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Novavax's current stock value. Our valuation model uses many indicators to compare Novavax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novavax competition to find correlations between indicators driving Novavax's intrinsic value. More Info.Novavax is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novavax's earnings, one of the primary drivers of an investment's value.Novavax Systematic Risk
Novavax's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Novavax volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Novavax correlated with the market. If Beta is less than 0 Novavax generally moves in the opposite direction as compared to the market. If Novavax Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Novavax is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Novavax is generally in the same direction as the market. If Beta > 1 Novavax moves generally in the same direction as, but more than the movement of the benchmark.
Novavax December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Novavax help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Novavax. We use our internally-developed statistical techniques to arrive at the intrinsic value of Novavax based on widely used predictive technical indicators. In general, we focus on analyzing Novavax Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Novavax's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 40.89 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 8.66 |
Complementary Tools for Novavax Stock analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |